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Introduction 71
The gut microbiota has been linked to colorectal cancer (CRC) in many studies [1] [2] [3] [4] [5] [6] [7] , and serves 72 as a very promising target for diagnostic, prophylactic, and therapeutic applications. Yet, despite 73
intense study, only a few microbial species-like Fusobacterium species-are consistently 74 7 of microbial community variance in comparison to sample location (proximal/distal and on/off 116 tumor), body mass index (BMI), age, and sex. Separate analyses of the dMMR and pMMR 117 microbial communities revealed that many common CRC-associated microbial signatures [9, 118 26]-including Fusobacterium nucleatum, Fusobacterium periodonticum, and Bacteroides 119 fragilis-were all enriched in dMMR but not pMMR tumors. Functional differences were 120 examined using a combination of metabolomics and community metabolic modeling. Our results 121 indicate greater predicted and actual hydrogen sulfide production in dMMR CRC as compared to 122 pMMR CRC, but no significant differences in predicted or actual butyrate production. Finally, 123 we approximated microbial ecology by modeling the metabolic interactions between microbes. 124
Overall, the pMMR microbial network was predicted to be more stable (resistant to 125 disturbances). Microbial community stability may play an important role in tumorigenesis, 126 cancer progression, and immune activation [22, 27, 28] , and only by examining predicted 127 microbial community interactions were we able to capture this dynamic. Our work demonstrates 128 distinct microbial, metabolic, and ecological attributes of dMMR and pMMR microbial 129 8 for colorectal cancer surgery were voluntarily enrolled at Mayo Clinic in Rochester, Minnesota. 138 Exclusion criteria included chemotherapy or radiation in the 2 weeks leading up to enrollment. 139 Total or partial colectomies were performed on every patient, and colon tissue and mucosal 140 samples were collected from tumor and normal-adjacent sites. Sample location was defined as 141 follows: "proximal" samples were derived from the cecum and ascending colon. "Distal" 142 samples were derived from the transverse, descending, or sigmoid colon, or rectum. MMR status 143 was determined in 83 patients: 25 had dMMR CRC and 58 had pMMR CRC ( Table 1) . We used 144 univariable logistic regression (R v3.1.2) to compare demographic (age, sex, BMI, smoking 145 history) and disease features (tumor location and stage) between dMMR and pMMR groups. 146 
Validation of differentially abundant microbes using an independent cohort 195
To validate the differentially abundant microbes associated with dMMR status, we investigated 196 data from a recent study that included microbiome profiling in tumor and matched normal tissue 197 samples in 44 CRC patients [1] . We categorized MMR status based on microsatellite instability 198
Microbial influence network 239
To select sOTUs for the Microbial Influence Networks (MINs), we used GLMM results to 240 choose tumor and normal-associated microbes in dMMR and pMMR samples with a linear 241 effect size greater than 0.25, regardless of statistical significance. Effect size captures biological 242 impact potential while significance measures certainty. In this case, we wanted to assess the 243 metabolic influence (i.e., biological impact) of microbes in relation to their respective microbial 244 communities; as such, it was more appropriate to filter by effect size. For each sOTU, the 16S 245 rRNA gene consensus sequence was aligned against complete genome in the PATRIC system 246 using VSEARCH v2.7.1, with a minimum nucleotide identity of 90%. When this procedure 247 generated multiple top hits, we selected a genome, in order, to the most complete genome (fewer 248 contigs), a type strain, a strain with a binomial name, and the closest match to the 16S taxonomy 249 (when possible). For each genome, we then reconstructed and downloaded its corresponding 250 genome-scale metabolic model using the PATRIC service. When sOTUs mapped to the same 251 model, we used that model only once, effectively merging those sOTUs in further analysis, with 252 an exception for when two sOTUs were associated with opposite conditions (i.e., tumor and 253 normal-adjacent samples), in which case we discarded that model from further consideration. 254
The decision to discard was also based on the observation that low identity hits or sOTUs with 255 taxonomy not sufficiently resolved were typically involved in these few cases. 256
257
After obtaining the genome-scale metabolic models (GEMs), we calculated "growth" on 258 complete media with no oxygen. This was done by calculating optimal metabolic reaction fluxes 259 14 using a Flux Balance Analysis[40], in which "growth" is the calculated flux of the reaction 260 defining biomass for a microbe. We did this using a tool for assessing microbial metabolic 261 interactions (MMinte) which evaluates the growth of microbes alone and when paired with 262 another microbe [41] . Once single and paired growth values were calculated using the objective 263 function given by MMinte [41] , these values were then used to calculate the influence score. properties weighed according to influence score and influence, respectively. Initial visualization 285
in Cytoscape was generated using the "Edge-weighted spring-embedded layout" with the 286 parameters modified to avoid node collisions according to what worked best in each of the two 287 cases. Node sizes and edge weights were likewise set according to the maximum and minimum 288 values in dMMR and pMMR networks separately. Interactions below 10 in the case of dMMR 289 and below 5 in the case of pMMR were excluded from the spring force layout computation in 290 order to achieve better readability of the final network figure. Unconnected nodes that had no 291 influence were not included in the visualization. 292 293
Predicting butyrate production 294
After we identified the most influential microbes in the dMMR and pMMR MINs, we then 295 assessed the butyrate-producing potential of these microbes. We used the previously selected 296 genome sequences for these microbes and queried the PATRIC service [44] for the presence of 297 the following genes: butyrate kinase (EC 2.7.2.7) or acetate CoA-transferase (EC 2.8.3.8). These 298 genes serve as markers for butyrate production pathways [45] . The presence of either gene was 299 considered sufficient to establish that a bacterium was capable of producing butyrate. 300
301
Results 302 dMMR tumors associated with older age and early stage, proximal tumors 303 A total of 25 individuals with dMMR CRC and 58 individuals with pMMR CRC were involved 304 in this study. Individuals with dMMR CRC were significantly older than individuals with pMMR 305 CRC and significantly more likely to have an early stage, proximal tumor ( Table 1) . As such, we 306 included age and sample location (proximal/distal and on/off tumor) as covariates in subsequent 307 analyses. 308
Tumor MMR status strongly predicts variance between microbial communities 309
To assess factors that contributed to variance in the microbial community data, we performed a 310 PERMANOVA analysis on unweighted UniFrac distances between microbial communities in 311 each sample. We included MMR status, sample location (proximal/distal, on/off tumor), age, 312 sex, BMI and sample type (colon tissue vs. mucosa) as potential predictors of the variance. 313
Remarkably, we found that MMR status explained more of the variance than any of the other 6 314 variables (Additional File 1: Table S2 ) even when MMR status was included as the last variable 315 in the model ( Table 2) . 316 
Distinct microbial communities associated with pMMR and dMMR tumors 321
Given the importance of MMR status to microbial community variance, we opted to assess 322 microbial abundances in tumor and normal samples for each MMR subtype independently. We 323 identified multiple differentially abundant sOTUs in dMMR and pMMR tumor samples as 324 compared to normal-adjacent samples using a generalized linear mixed model (GLMM) that 325 accounted for sample location, sample type, and intrasubject sample correlation ( Fig. 2 ; 326 Additional File 1: Figure S1 (Venn diagram showing counts of microbes in each group), Table  327 S3 (table of microbes enriched in dMMR), Erysipelotrichaceae bacterium (p=0.007, FDR p=0.31) (Additional File 1: Figure S2 ). Even 346 though these associations were not statistically significant after correcting for FDR, their trend of 347 association overlaps with the results from the present study. Differentially abundant sOTUs 348 between pMMR tumors versus normal included Ruminococcaceae, Faecalibacterium prausnitzii 349 and Bacteroides caccae, which were also differentially abundant in the present study. As sulfidogenic F. nucleatum and F. periodonticum were also significantly enriched in dMMR 361 tumor samples, we decided to assess potential hydrogen sulfide production across groups 362 (dMMR/pMMR, tumor/normal) by modeling hydrogen sulfide flux. We used microbial 363 community metabolic models to predict hydrogen sulfide flux within each microbial community 364 (dMMR tumor and normal, pMMR tumor and normal). The models produced a non-significant 365 trend towards increased hydrogen sulfide flux in dMMR tumor samples ( Fig. 3a) . To get a more 366 concrete measure of hydrogen sulfide production, we ran targeted metabolomics to quantify 367 amino acid proxies (serine, homoserine, lanthionine, L-cystathionine, D-cystathionine) for 368 hydrogen sulfide in dMMR and pMMR tumor and normal tissue samples (Fig. 3b) . We observed 369 a significant increase in lanthionine in dMMR tumor tissue over dMMR or pMMR normal tissue 370 and pMMR tumor. Homoserine and L-Cystathionine were also significantly increased in both 371 dMMR and pMMR tumor tissue as compared to normal-adjacent tissue. The metabolomics 372 results suggest increased hydrogen sulfide production in tumor tissue-particularly in dMMR 373 tumor tissue. 374 375 pMMR microbial community predicted to be more stable and to suppress F. nucleatum 376 20 To further assess the potential metabolic interactions between tumor and normal-adjacent 377 microbes in relation to MMR status, we constructed two metabolic influence networks (MIN; 378 Fig. 1)[42] . The MIN highlights each microbe's predicted influence and interactions (growth 379 enhancing or suppressing) in relation to other microbes in the community. We also evaluated an 380 indirect measure of ecological stability[51] based on the percentage of predicted positive and 381 negative interactions present within a given microbial community. Notably, the more negative 382 interactions present within a community, the more stable that community is predicted to be[51]. 383
The dMMR microbial community exhibited 21.1% negative interactions while the pMMR 384 microbial community exhibited significantly more (47.6%, binomial test, p<0.0001), suggesting 385 that the pMMR community is more stable. 
Highly influential microbes include many butyrate producers 394
Within the MINs, microbes that exhibit many or strong interactions with other microbes-either 395 influencing or being influenced by-are classified as influential microbes. To examine the most 396 influential microbes within each MIN, we identified all microbes with an influence score of 0.5 397 standard deviations above the mean for dMMR and pMMR microbes, respectively (Tables 3 -398 21 dMMR, 4 -pMMR). Characterization of the most influential microbes revealed that many of 399 these microbes are butyrate producers. 400 Table 3 . List of basic properties for the most influential microbes in the dMMR MIN. 
415

Butyrate production did not differ between dMMR and pMMR microbial communities 416
Given the predicted influence and differential abundance of butyrate-producing microbes in 417 dMMR and pMMR, we decided to compare the butyrate-producing potential of the most 418 influential tumor-associated microbes in dMMR and pMMR MINs by searching for genes 419 involved in butyrate production within the functional annotation of these genomes in PATRIC. 420
There were no significant differences in butyrate production-associated genes between dMMR 421 and pMMR tumor-associated microbes ( Table 5 ; Wilcoxon rank-sum test, p>0.05). To more 422 fully assess community-wide butyrate production, we performed targeted metabolomics to 423 quantify SCFA concentrations in tumor and normal-adjacent colon tissue. With the exception of 424 isocaproic acid, which was significantly increased in dMMR tumor tissue, there were no 425 significant differences in SCFA concentrations-including butyrate-between dMMR tumor and 426 normal-adjacent or pMMR tumor and normal-adjacent tissue samples (Fig. 4) . 427 
431
To further explore how the dMMR MIN could have multiple strongly influential butyrate-432 producing microbes but no increase in butyrate production, we examined the predicted 433 interactions (positive and negative) of the most influential butyrate producers in the dMMR MIN 434 network (identified in Table 3 ). We found that butyrate producers were targets of more negative 435 interactions (26% negative interactions) as compared to all negative interactions in the dMMR 436 MIN network (21% negative interactions), suggesting growth suppression of butyrate producers 437 in the dMMR community (binomial test, p = 0.02). In contrast, the most influential butyrate 438 producers in the pMMR MIN network (identified in Table 4 ) were not a target for increased 439 negative interactions (binomial test, p = 0.08). We repeated this analysis using all differentially 440 abundant major butyrate producers in dMMR and pMMR microbial communities (identified in 441 Fig. 2) . We found that while all butyrate producers (in dMMR or pMMR microbial 442 communities) were more likely to be targets of negative interactions, this was more strongly 443 evident in the dMMR microbial community (dMMR binomial test: p=6E-13, pMMR binomial 444 test p=0.008). 445
446
Discussion 447
This study integrates tumor biology and microbial ecology in a novel and powerful approach to 448 understanding colorectal cancer. Our results indicate that MMR status is one of the strongest 449 predictors of microbial community variance; however, few studies [23, 24], to date, include 450 24 MMR status in microbial community analysis of colorectal cancer. Interestingly, we also 451 identified several differentially abundant microbes associated with dMMR but not pMMR tumor 452 samples including F. nucleatum, F. periodonticum, and B. fragilis. We further validated these 453 findings in an independent cohort [1] , which underscores the importance of including MMR 454 status in future CRC microbiome studies. We additionally characterized the predicted and actual 455 metabolic profiles of dMMR and pMMR individuals in relation to hydrogen sulfide and butyrate 456 production, and we generated a network of predicted interactions within the dMMR and pMMR 457 microbial communities. 458
459
Hydrogen sulfide has been reported to both promote and inhibit colorectal cancer [70-73]. To 460 assess the role of hydrogen sulfide within our study, we looked for sulfidogenic bacteria, 461 predicted hydrogen sulfide production using community metabolic models, and measured 462 hydrogen sulfide concentrations through targeted metabolomics for amino acid proxies. We 463 found two significantly enriched hydrogen sulfide-producing Fusobacterium species and 464 significantly increased hydrogen sulfide concentrations in dMMR tumor samples. In the 465 microbial influence network, both Fusobacterium species exhibited zero predicted interactions-466 positive or negative-with other microbes in the network. Together, this suggests that these 467
Fusobacterium species grow abundantly and unchecked by other microbes, and have the 468 potential to produce large quantities of hydrogen sulfide. In contrast, the F. nucleatum found in 469 pMMR MIN was predicted to be the target of 34 (100%) negative interactions, suggesting that its 470 growth and metabolic output (hydrogen sulfide) are highly suppressed in pMMR individuals. CRC mouse model showed that microbially-produced butyrate accelerated tumorigenesis [24] , 500
indicating that the source of this paradox may have to do with the genetic model of CRC being 501 used and that butyrate may therefore have different, even opposite, roles in different CRC 502 subtypes. It was therefore intriguing that more butyrate producers were identified as highly 503 influential in the dMMR MIN as compared to pMMR MIN. However, neither predicted 504 (functional annotation) nor actual (metabolomic data) butyrate production differed significantly 505 between dMMR and pMMR samples or tumor and normal samples in the metabolomic profile. 506
One potential reason for this lack of difference surfaced when we examined the number of 507 negative interactions targeted at butyrate producers in the dMMR and pMMR MINs. dMMR 508 butyrate producers had a significantly higher probability of negative interactions as compared to 509 pMMR butyrate producers. This suggests that, though present, these butyrate producers are being 510 suppressed in dMMR microbial communities. 511 512 Negative interactions were also predicted to be significantly increased in the pMMR microbial 513 community as a whole versus the dMMR microbial community. Negative interactions, implying 514 competition, are an ecological hallmark of a stable community[51], which is both resistant and 515 resilient to disturbance. We speculate that a less stable microbial community in dMMR 516 individuals could mean constant community shifts and disturbances-resulting in increased 517 27 immune activation. The dMMR tumor phenotype is associated with increased immune 518 response [74] , which may play a role in inhibiting cancer cell proliferation of dMMR tumors. 519 520 Overall, our study demonstrates the importance and value in considering tumor biology (MMR 521 status) and ecological interactions when evaluating microbial community data. Our work is 522 primarily descriptive and incorporates host clinical features, microbiome, metabolome, and 523 modeling data. While we make speculations based on these data, future prospective and 524 mechanistic studies are needed to test these ideas. We also recognize that selecting sequenced 525 genomes available in the database to represent 16S rRNA sOTUs cannot fully replace 526 metagenomic sequencing given well-known strain-to-strain variation in gene content. However, 527 these variations between strains are often largely in secondary metabolite pathways, rather than 528 core metabolic function, which is the main target of our modeling analysis. 529 530 Another limitation of this study is our inability to attribute a source to metabolomic data. While 531 butyrate is a microbial fermentation product, hydrogen sulfide and its amino acid proxies can be 532 produced by both humans and bacteria. Thus, the enriched hydrogen sulfide we detect in dMMR 533 tumor samples could potentially be attributed to increased hydrogen sulfide production within 534 tumor tissue, and indeed, this has been reported [73] . If this was the solely case here however, we 535 might expect to see similar increases in hydrogen sulfide in pMMR tumors-most of which are 536 later in stage than dMMR tumors. We did not see this, suggesting that it is feasible that the 537 increased hydrogen sulfide production in dMMR tumors is coming from an exogenous 538 (microbial) source. Notably, microbially produced hydrogen sulfide can be generated from 539 28 multiple pathways including the respiration of dietary taurine and sulfate as well as the 540 degradation of sulfomucins. The amino acid proxies we use to assess hydrogen sulfide 541 production only capture some, but not all of these potential pathways, so we may have 542 underestimated hydrogen sulfide production. This study provides a novel framework in which to examine colorectal cancer: 554 1. Host-microbe interactions: Tumor MMR status strongly predicted microbial community 555 variance and was associated with distinct microbial, metabolic, and interaction profiles. 556
Our approach incorporating tumor MMR status, microbiome, metabolome and modeling 557 data allowed us unique insights into the role of hydrogen sulfide and hydrogen sulfide 558 producers within the dMMR microbial community. Tumor biology (e.g. MMR status) 559 and microbial ecology are inextricably linked, and it is critical that future studies account 560 for both in order to understand and more precisely classify the many pathways to CRC. 561 29 2. Microbe-microbe interactions: Microbial influence networks provided in silico 562 predictions of community stability and microbial interactions that aligned with in vivo 563 metabolomics data: Suppression of sulfidogenic F. nucleatum and significantly lower 564 hydrogen sulfide production in pMMR, and suppression of butyrate-producing bacteria 565 in dMMR-which may explain the lack of difference in butyrate production between 566 dMMR and pMMR samples. The validation of in silico data with in vivo tests provides 567 support for a future of precision medicine tools that can accurately predict disease and the 568 potential effects of prophylactic or therapeutic interventions on the microbiome. 569
Microbes act within communities, and understanding and predicting these interactions 570 will be key to developing targeted mechanisms to help prevent or treat colorectal cancer. 571 572 Acknowledgements 573
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